mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |